← FDA Drug Approvals (Drugs@FDA)

OLOPATADINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2020-05-20

Drug application

FDA Application #

ANDA209752

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLOPATADINE HYDROCHLORIDE

Generic name

OLOPATADINE HYDROCHLORIDE

Active ingredients

OLOPATADINE HYDROCHLORIDE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Over-the-counter

Sponsor

GLAND

Manufacturer

Rugby Laboratories

First approval

2020-05-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown